You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

When Is Weight Loss Concerning in Older Adults?

  • Authors: News Author: Nancy A. Melville; CME Author: Charles P. Vega, MD
  • CME / ABIM MOC / CE Released: 5/19/2023
  • Valid for credit through: 5/19/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care clinicians, geriatricians, nurses, physician assistants, and other members of the healthcare team who care for older adults.

The goal of this activity is for learners to be better able to analyze the effects of weight and waist circumference changes on mortality outcomes among older adults.

Upon completion of this activity, participants will:

  • Assess changes in body composition associated with age
  • Analyze the effects of weight and waist circumference changes on mortality outcomes among older adults
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Nancy A. Melville

    Freelance writer, Medscape

    Disclosures

    Nancy A. Melville has no relevant financial relationships.

CME Author

  • Charles P. Vega, MD

    Health Sciences Clinical Professor of Family Medicine
    University of California, Irvine School of Medicine

    Disclosures

    Charles P. Vega, MD, has the following relevant financial relationships:
    Consultant or advisor for: Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Editor/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 05/19/2024. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

When Is Weight Loss Concerning in Older Adults?

Authors: News Author: Nancy A. Melville; CME Author: Charles P. Vega, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 5/19/2023

Valid for credit through: 5/19/2024

processing....

Clinical Context

The body changes as we move into older age, and a review by Gaddey and Holder examined some of the causes and consequences of weight loss among older adults. Their work was published in the July 2021 issue of American Family Physician.[1]

Weight loss among older adults is not due to changes in appetite or psychosocial reasons alone, although these are important points of pathology for many senior citizens. Inflammatory biomarkers are elevated among adults with weight loss, suggesting another pathological mechanism.

The result is a loss of lean body mass, which is normal among adults. Lean body mass can start declining by an average of 0.3 kg/y even between the ages of 20 and 30 years. Meanwhile, fat mass generally increases until age 65 to 70 years. Therefore, body weight rarely increases substantially after age 60 years.

Nonetheless, these changes alone should not result in an unintentional body weight loss in excess of 5% over 12 months, at which time a workup for a secondary cause of weight loss should be investigated. Weight loss and cachexia have been associated with negative health outcomes among older adults, and the current study by Hussain and colleagues uses a large cohort to assess the effects of weight changes on mortality among older adults.

Study Synopsis and Perspective

Weight loss in otherwise healthy older adults is linked to an increased risk for mortality, even from conditions not typically associated with weight change, with a substantially stronger link in men vs women, suggesting the need for clinicians to be alert to such changes.

"Our study emphasizes the importance of weight loss even in relatively healthy individuals who are free from evident cardiovascular disease (CVD), dementia, physical disability, or life-limiting chronic illness," first author Monira Hussain, MBBS, MPH, PhD, told Medscape Medical News.

"Clinicians should be aware that even minor weight loss of 5% or more in older adults without life-limiting illnesses can increase mortality risk," Hussain said. "Regular monitoring of weight changes can help early identification of associated risks."

The study was published April 3 in JAMA Network Open.[2]

The researchers noted that data on the significance of weight changes among older individuals who are otherwise relatively healthy and not diagnosed with life-limited diseases are limited, with the exception that "it is widely acknowledged that weight loss may precede a diagnosis of cancer," they said.

Still, the association with the other types of non--cancer-related premature death is notable.

"In our study, weight loss also preceded an increased mortality from CVD and other causes, [such as] deaths from trauma, dementia, Parkinson disease, and other less common causes," the authors continued.

Therefore, "a likely explanation for these findings is that weight loss can be an early prodromal indicator of the presence of various life-shortening diseases," wrote Hussain, of the School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia, and colleagues.

In terms of why weight loss shows such a stronger link to mortality in older men compared with women, Hussain speculated that this may be due to "differences in body composition" between the two sexes.

"Men have a higher proportion of muscle and bone mass, and weight loss [in men] primarily involves loss of these tissues," she observed.

Quadruple Risk for Premature Death Among Men With 10% Weight Loss

To investigate this phenomenon, the researchers conducted a post hoc analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) randomized trial, which included information on a variety of body size parameters, such as weight and waist circumference, measured annually, from a large population of healthy individuals with no evident CVD, dementia, physical disability, or life-limiting chronic illness.

The 16,523 participants included in the study had a mean age of 75 ± 4.3 years, and 55.6% were women. During a mean follow-up of 4.4 ± 1.7 years, 1256 deaths occurred in the cohort.

Looking at rates of all-cause mortality, stratified by gender, the results showed that among men who had a 5% to 10% decrease in weight over the course of the study, the risk for all-cause mortality was 33% higher than among men who had a stable weight (< 5% change; hazard ratio [HR] 1.33).

Among men who had a more than 10% decrease in weight, the mortality risk was as much as 289%, or nearly 4 times higher compared with men with a stable weight (HR 3.89).

For women, the mortality risk was also increased, however, to a lesser degree. A 5% to 10% loss of body weight was associated with a 26% increased mortality risk (HR 1.26), and a loss of more than 10% was linked to a 114% increased risk for all-cause mortality (HR 2.14).

In terms of cancer-specific deaths, the risk was significantly increased only among men who had a greater than 10% weight decrease (HR 3.49), whereas the increased risk in women was observed with a 5% to 10% decrease in weight (HR 1.44) as well as a more than 10% decrease (HR 2.78).

The risk for CVD-specific death was significantly increased with a more than 10% decrease in weight in both sexes, but the risk was again higher among men (HR 3.14) than among women (HR 1.92) compared with stable weight groups.

And the non-cancer, non--CVD-specific mortality risk was nearly 5 times higher among men who had a more than 10% decrease in weight vs stable weight (HR 4.98); however, the association was not significant among women (HR 1.49).

Looking at the effects of change in waist circumference, a decrease of more than 10% was associated with a higher risk in all-cause mortality that was again higher for men (HR 2.14) vs women (HR 1.34); however, no link with all-cause mortality was observed with a less than 10% decrease in either sex.

A greater than 10% decrease in waist circumference was also associated with higher risk for cancer death for men and women, and higher non-cancer, non-CVD death among men, but not women, whereas there was no association between waist circumference and CVD mortality in men or women.

Association With Mortality Remained After Adjusting for Hospitalization

The results persisted after adjustment for age, frailty status, baseline body mass index (BMI), country of birth, smoking, hypertension, diabetes, and hospitalization in the previous 24 months.

The adjustment for recent hospitalization was especially important for ruling out weight loss that may have occurred due to hospitalization for acute conditions that could have contributed to mortality, the authors noted.

The authors have reported no relevant financial relationships.

Study Highlights

  • Investigators drew study data from the Aspirin in Reducing Events in the Elderly (ASPREE), a randomized trial of daily aspirin therapy among community-dwelling adults aged ≥ 65 years. The study was conducted in Australia and the United States and was active between 2010 and 2014.
  • The study analysis excluded adults with preexisting CVD, disability, or severe illness expected to result in death within 5 years.
  • Study participants completed quarterly assessments via telephone and annual wellness examinations.
  • The main study variables were body weight and waist circumference.  Variance of < 5% from the baseline body weight and waist circumference at 2 years was considered normal.
  • The main study outcome was overall mortality, with secondary outcomes of cancer and cardiovascular (CV) mortality.
  • 16,523 participants provided data for the current study. 55.6% were women, and the mean age was 75 ± 4.3 years. The mean body weight and waist circumference values at baseline were 77.1 ± 14.8 kg and 97.1 ± 12.7 cm, respectively.
  • 1256 participants died over a mean 4.4 ± 1.7 years of follow-up.
  • Three-quarters of the study cohort maintained a stable body weight over 2 years. 7.9% of participants had a 5% to 10% increase in body weight, and 1.9% had an increase of > 10%. 11.8% of participants lost 5% to 10% of their baseline body weight, and 3.6% lost > 10%.
  • Significant weight loss of > 5% was associated with being a woman, prefrail or frail status, and being from the United States.
  • The HR for mortality in comparing men who lost 5% to 10% of their body weight vs men with stable weight was 1.33 (95% CI: 1.07, 1.66). The respective HR for men who lost > 10% of their body weight was 3.89 (95% CI: 2.93, 5.18).
  • The HR for mortality in comparing women who lost 5% to 10% of their body weight vs women with stable weight was 1.26 (95% CI: 1, 1.6). The respective HR for women who lost > 10% of their body weight was 2.14 (95% CI: 1.58, 2.91).
  • Weight loss in excess of 10% was associated with a higher risk for cancer mortality among men (HR 3.49 [95% CI:  2.26, 5.4]), but more modest weight loss between 5% to 10% was not. Women who lost ≥ 5% of baseline body weight were at significant risk for cancer mortality.
  • Weight loss in excess of 10% was associated with a higher risk for CV mortality among men (HR 3.14 [95% CI: 1.63, 6.04]) and women (HR 1.92 [95% CI: 1.05 to 3.51]).
  • Men, but not women, experienced a higher risk for mortality not related to cancer or CVD when they experienced weight loss of > 10% from baseline.
  • Weight gain, even > 10% of baseline body weight, was not associated with a higher risk for mortality, save for a possible association of death due to causes other than cancer or CVD among women.
  • A decline in waist circumference of > 10% was associated with an HR of 2.14 (95% CI: 1.57, 2.91) among men, and an HR of 1.34 (95% CI: 1.02, 1.78) among women. Milder reductions in waist circumference and increases in waist circumference were not associated with a higher risk for mortality.

Implications for the Healthcare Team

  • Lean body mass can start declining by an average of 0.3 kg/y even between the ages of 20 and 30 years. Meanwhile, fat mass generally increases until age 65 to 70 years. Therefore, body weight rarely increases substantially after age 60 years.
  • In the current study by Hassain and colleagues, weight loss among older adults was significantly associated with higher risks for overall, cancer-related, and CV mortality. This effect was more profound among men compared with women, and weight gain did not confer a similar higher risk for mortality. Reductions in waist circumference beyond 10% were also associated with a higher risk for mortality.
  • The healthcare team should monitor body weight in older adults and investigate cases of unintentional weight loss.

 

Earn Credit

  • Print